Blueprint Medicines(BPMC) - 2025 Q1 - Earnings Call Presentation

Blueprint Medicines Driving growth and innovation with operational excellence First quarter 2025 financial and operating results INTRODUCTION AYVAKIT PERFORMANCE Kate Haviland Chief Executive Officer Philina Lee, PhD Chief Commercial Officer PROGRESS May 1, 2025 First quarter 2025 financial and operating results Becker Hewes, MD Chief Medical Officer FINANCIAL RESULTS Mike Landsittel Chief Financial Officer 2 CLINICAL Forward-looking statements This presentation contains forward-looking statements within th ...